IPO Valuation vs. Listing-Day Reality: Lessons from India’s 2026 Startup Listings

An IPO subscribed 30 times can list below its issue price. One subscribed almost 100 times can open way up. Both happened this year.

Amagi’s issue was subscribed 30.24 times and still opened 11.9% below its issue price on the NSE. Shiprocket was subscribed 99.38 times and opened 35.1% above. Same market, same year, very different first days.

So what do the 2026 listings actually tell us about valuation? Here’s what stood out, and what founders can take from it before they price an issue.

1. Subscription Shows Demand, Not Fair Value

Subscription tells you how many people wanted shares at the offer price. That’s all it tells you. The listing price comes from trading once the shares are out in the open market, and that is a separate thing.

Fractal Analytics was subscribed just 2.66 times and opened only 2.7% below issue. Amagi, at 30 times, did worse than that. If subscription were a verdict on valuation, those two would have gone the other way.

What this means:

• A big subscription number is a good sign of demand
• It doesn’t settle whether the issue price was right

2. A Good Average Hides Very Different Debuts

Moneycontrol reported that 87 companies had debuted by 30 September, with an average listing-day gain of 14%. In 2025 that figure was 9.3%. Sounds great.

Then you look at individual names. ESDS Software Solution opened at a 76.5% premium. Amagi, Shadowfax, Turtlemint and AceVector, among others, opened below their issue prices. An average smooths all of that out.

Coverage this year also kept coming back to investor caution around cash burn, profitability and governance. That helps explain the mood, but no single factor explains why one company listed up and another listed down.

3. Profit Didn’t Predict the Pop

Here are ten of this year’s listings side by side. Profits are shown as positive numbers and losses in brackets.

Subscription, issue price and NSE opening price as reported; opening move calculated from issue price.

ESDS, Moneyview and Kissht reported FY26 profits and opened above issue. Fair enough. Then Shiprocket reported a net loss of ₹79.3 crore and still opened 35.1% higher. Purple Style Labs posted a wider loss and opened lower.

Turtlemint is still loss-making, though its audited full-year loss narrowed to ₹184.3 crore in FY26 from ₹194.1 crore in FY25. It opened 11.3% below issue anyway.

Earnings matter. So do the offer price, the sector, what investors expected and how the market felt that week. There’s no simple rule linking profit to a listing premium.

4. Shadowfax: Day One Was Only the Start

Shadowfax priced at ₹124 and opened at ₹112.60 on 28 January, a 9.2% discount. Someone who bought a 120-share lot at issue and sold at the open was down ₹1,368 before charges and taxes.

Then the stock moved. At 12:46 p.m. IST on 16 October, a market quote page showed it around ₹288, roughly 132.3% above the issue price.

The company reported H1 FY26 operating revenue growth of 68.4% and net profit of ₹21 crore, up from ₹9.8 crore a year earlier. FY26 PAT came in at about ₹112 crore. Those numbers give context for the move, though they don’t fully explain it.

One day’s price is one data point. Over time, what matters is whether the business delivers what investors paid for.

5. Valuations Got Reset Before Listing Too

A few big names changed or delayed their plans in 2026:

• Curefoods: reports in June said the IPO was put on hold after mutual funds questioned the roughly ₹4,000 crore valuation it sought. That was a reported target, not a final valuation.
• PhonePe: Reuters reported it paused its plans in March amid geopolitical tension and market volatility. Inc42 later reported a February to March 2027 window, which is still only a plan.
• Zepto: reportedly eyeing February to May 2027. Its filed FY26 net loss was ₹5,905.2 crore against ₹4,699.7 crore in FY25, about 25.7% higher. Accounting loss and cash burn are different measures, so keep them apart.
• Razorpay: a possible IPO valuation of $5 to 6 billion was reported, against roughly $7.5 billion in its 2021 private round. It’s a media-reported range, not a confirmed number.
• Moneyview: cut its fresh issue from ₹1,500 crore to ₹750 crore. The ₹750 crore is only the fresh issue, as the IPO also had an offer for sale. Management pointed to its capital needs and profitability trajectory.

A past funding round is not a guaranteed IPO price. Private and public markets set value under very different conditions.

6. What Public Market Investors Look At

Inc42’s coverage of the 2026 IPO market kept highlighting predictable cash flows, sustainable unit economics and operational discipline. Investors and analysts quoted there also talked about governance, capital efficiency and comparisons with listed peers.

Treat that as reported opinion. It’s not a survey of every public market investor.

7. What Founders Can Do Before Setting the Price

Before filing the DRHP: Build your own independent view of value. Test the assumptions against relevant listed peers as well as the last private round.

Before fixing the price band: Ask what happens if the debut is flat or negative. Look at the mix of fresh issue and offer for sale, and be clear about how the fresh issue money will be used.

After listing: Track real operating and financial results against what you presented at the IPO. Judge the business over time, not on one day’s trading.

8. How ValuGenius Can Help

At ValuGenius, we help founders and finance teams assess valuation ahead of big decisions like an IPO. The right scope and method depend on your company and what the valuation is for. Before work begins, we agree on the information needed, the methods to consider and the deliverables, so assumptions and limitations are clear to everyone.

If you’re preparing for an IPO or another valuation decision, get in touch with ValuGenius to talk through your company’s needs, the scope and the next steps.